Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. It operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and a range of other merchandise, including over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products. It also operates retail clinics that provide treatment for common conditions; and a range of preventive services comprising screenings, medical tests, immunizations, and basic physical exams. In addition, this segment offers healthcare coaching and disease management services. The Pharmacy Services segment provides pharmacy benefit management (PBM) services and a range of pharmacy-related services. This segment also performs prescription adjudication services for other PBMs; and offers integrated mail-order, specialty and compounding pharmacy, and infertility treatment services, as well as drug benefits under the federal government's Medicare Part D program. As of April 12, 2018, the company operated approximately 2,548 stores in 19 states. Rite Aid Corporation was founded in 1927 and is headquartered in Camp Hill, Pennsylvania.
Industry, Sector and Symbol
Industry Drug stores & proprietary stores
Sub-IndustryDrug Retail
SectorRetail/Wholesale
Phone717-761-2633
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$21.53 billion
Profitability
Miscellaneous
Employees59,000
Next Earnings Date4/11/2019 (Estimated)
OptionableOptionable
Rite Aid (NYSE:RAD) Frequently Asked Questions
What is Rite Aid's stock symbol?
Rite Aid trades on the New York Stock Exchange (NYSE) under the ticker symbol "RAD."
How were Rite Aid's earnings last quarter?
Rite Aid Co. (NYSE:RAD) issued its quarterly earnings results on Thursday, September, 27th. The company reported ($0.01) earnings per share (EPS) for the quarter, hitting the Zacks' consensus estimate of ($0.01). The business earned $5.42 billion during the quarter, compared to analyst estimates of $5.36 billion. Rite Aid had a negative return on equity of 0.94% and a net margin of 2.85%. Rite Aid's revenue for the quarter was up 1.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted ($0.01) EPS. View Rite Aid's Earnings History.
When is Rite Aid's next earnings date?
What price target have analysts set for RAD?
5 Wall Street analysts have issued twelve-month price objectives for Rite Aid's stock. Their forecasts range from $1.00 to $6.00. On average, they anticipate Rite Aid's share price to reach $2.20 in the next twelve months. This suggests a possible upside of 226.2% from the stock's current price. View Analyst Price Targets for Rite Aid.
What is the consensus analysts' recommendation for Rite Aid?
5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rite Aid in the last year. There are currently 1 sell rating and 4 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Rite Aid.
Has Rite Aid been receiving favorable news coverage?
News stories about RAD stock have been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Rite Aid earned a news impact score of 0.6 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term.
Are investors shorting Rite Aid?
Rite Aid saw a increase in short interest in the month of February. As of February 28th, there was short interest totalling 126,483,717 shares, an increase of 1.0% from the February 15th total of 125,291,076 shares. Based on an average trading volume of 8,711,539 shares, the short-interest ratio is currently 14.5 days. Approximately 11.9% of the shares of the company are short sold. View Rite Aid's Current Options Chain.
Who are some of Rite Aid's key competitors?
What other stocks do shareholders of Rite Aid own?
Who are Rite Aid's key executives?
Rite Aid's management team includes the folowing people:
- Mr. John T. Standley, CEO & Director (Age 56)
- Mr. Kermit Ray Crawford, Pres & COO (Age 60)
- Mr. Darren Wayne Karst, Sr. EVP, CFO & Chief Admin. Officer (Age 59)
- Ms. Jocelyn Zazyczny Konrad, Exec. VP of Pharmacy (Age 49)
- Mr. Bryan B. Everett, Chief Operating Officer of Rite Aid Stores (Age 46)
Who are Rite Aid's major shareholders?
Rite Aid's stock is owned by a variety of of retail and institutional investors. Top institutional investors include BlackRock Inc. (7.07%), Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp (2.26%), Northern Trust Corp (1.15%), Geode Capital Management LLC (1.03%), Geode Capital Management LLC (1.03%) and Norges Bank (0.85%). View Institutional Ownership Trends for Rite Aid.
Which institutional investors are selling Rite Aid stock?
RAD stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Private Management Group Inc., Dimensional Fund Advisors LP, Dimensional Fund Advisors LP, Bank of New York Mellon Corp, Gabelli Funds LLC, Two Sigma Advisers LP and Stone Ridge Asset Management LLC. View Insider Buying and Selling for Rite Aid.
Which institutional investors are buying Rite Aid stock?
RAD stock was purchased by a variety of institutional investors in the last quarter, including Norges Bank, BlackRock Inc., Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp, Geode Capital Management LLC, Geode Capital Management LLC, SG Americas Securities LLC, Hsbc Holdings PLC and Cumberland Advisors Inc.. View Insider Buying and Selling for Rite Aid.
How do I buy shares of Rite Aid?
Shares of RAD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Rite Aid's stock price today?
One share of RAD stock can currently be purchased for approximately $0.6744.
How big of a company is Rite Aid?
Rite Aid has a market capitalization of $728.29 million and generates $21.53 billion in revenue each year. The company earns $943.47 million in net income (profit) each year or ($0.02) on an earnings per share basis. Rite Aid employs 59,000 workers across the globe.
What is Rite Aid's official website?
How can I contact Rite Aid?
Rite Aid's mailing address is 30 Hunter Lane, Camp Hill PA, 17011. The company can be reached via phone at 717-761-2633 or via email at [email protected]
MarketBeat Community Rating for Rite Aid (NYSE RAD)
MarketBeat's community ratings are surveys of what our community members think about Rite Aid and other stocks. Vote "Outperform" if you believe RAD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RAD will underperform the S&P 500 over the long term. You may vote once every thirty days.
